Molecular Insight Pharmaceuticals, Inc. (Public, NASDAQ:MIPI) is UP about 30% this morning ... trading @ $2.10. They have a 52-week range of 1.05 - 7.90.
If you recall, on Tuesday, these guys initially shot up about 70% to reach a high that day of $2.35 ... since then, they drifted lower and closed yesterday @ $1.63.
Just for background, here's what they do:
Corporate Profile
Molecular Insight Pharmaceuticals is a clinical-stage biopharmaceutical company and is a pioneer in the emerging field of molecular medicine. The Company is focused on the discovery and development of targeted therapeutic and molecular imaging radiopharmaceuticals, primarily for use in oncology. Molecular Insight has five clinical-stage candidates in development. The lead oncology candidate, Azedra™, is currently in a pivotal trial for pheochromocytoma. Onalta™ is being developed for the treatment of carcinoid and other neuroendocrine tumors, Solazed™ for treatment of malignant metastatic melanoma, and Trofex™ for detecting metastatic prostate cancer. Zemiva™ is being developed for the diagnosis of acute myocardial ischemia.
MIPI is UP about 30% !!!
Re: MIPI is UP about 30% !!!
Trade in the stock market with Ranbaxy and make sure shot profit..
Buy Ranbaxy Laboratories Ltd above 449 SL 446 target 452.45, 456
For more stock calls visit@ http://stocks-intraday.blogspot.com/
Buy Ranbaxy Laboratories Ltd above 449 SL 446 target 452.45, 456
For more stock calls visit@ http://stocks-intraday.blogspot.com/
Who is online
Users browsing this forum: No registered users and 22 guests